Literature DB >> 15919009

[Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)].

I Alfageme, J Aspa, S Bello, J Blanquer, R Blanquer, L Borderías, C Bravo, R de Celis, X de Gracia, J Dorca, J Gallardo, M Gallego, R Menéndez, L Molinos, C Paredes, O Rajas, J Rello, F Rodríguez de Castro, J Roig, F Sánchez-Gascón, A Torres, R Zalacaín.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15919009      PMCID： PMC7131668     

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN： 0300-2896            Impact factor:   4.872


× No keyword cloud information.
  24 in total

1.  Epidemiology of community-acquired pneumonia in adults: a population-based study.

Authors:  J Almirall; I Bolíbar; J Vidal; G Sauca; P Coll; B Niklasson; M Bartolomé; X Balanzó
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

2.  [Site of care provision, etiology and treatment of community-acquired pneumonia in Palma de Mallorca].

Authors:  C Santos de Unamuno; M A Llorente San Martín; E Carandell Jäger; M Gutiérrez García; M Riera Jaume; A Ramírez Rosales; A Pareja Bezares; A Corrales Nadal
Journal:  Med Clin (Barc)       Date:  1998-03-07       Impact factor: 1.725

3.  Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.

Authors:  R Menéndez; J Córdoba; P de La Cuadra; M J Cremades; J L López-Hontagas; M Salavert; M Gobernado
Journal:  Am J Respir Crit Care Med       Date:  1999-06       Impact factor: 21.405

4.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

5.  Severe community-acquired pneumonia. Etiology, prognosis, and treatment.

Authors:  J Pachon; M D Prados; F Capote; J A Cuello; J Garnacho; A Verano
Journal:  Am Rev Respir Dis       Date:  1990-08

6.  Prospective study of the aetiology and outcome of pneumonia in the community.

Authors:  M A Woodhead; J T Macfarlane; J S McCracken; D H Rose; R G Finch
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

7.  [Epidemiology of community-acquired pneumonia in the Health Area I of Navarra].

Authors:  M M Carrillo de Albornoz; J H Pérez de Heredia; J Sánchez Alvarez; G Tiberio López; R Hernández Palacios; A Rivero Puente
Journal:  Med Clin (Barc)       Date:  1991-06-08       Impact factor: 1.725

8.  A three-year study of severe community-acquired pneumonia with emphasis on outcome.

Authors:  J Rello; E Quintana; V Ausina; A Net; G Prats
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

9.  Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

Authors:  J Blanquer; R Blanquer; R Borrás; D Nauffal; P Morales; R Menéndez; I Subías; L Herrero; J Redón; J Pascual
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

10.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.

Authors:  O Leroy; C Santré; C Beuscart; H Georges; B Guery; J M Jacquier; G Beaucaire
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440
View more
  15 in total

1.  Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay.

Authors:  L A Ruiz; A Gómez; C Jaca; L Martínez; B Gómez; R Zalacain
Journal:  Infection       Date:  2010-09-29       Impact factor: 3.553

2.  Increased incidence of co-infection in critically ill patients with influenza.

Authors:  Ignacio Martin-Loeches; Marcus J Schultz; Jean-Louis Vincent; Francisco Alvarez-Lerma; Lieuwe D Bos; Jordi Solé-Violán; Antoni Torres; Alejandro Rodriguez
Journal:  Intensive Care Med       Date:  2016-10-05       Impact factor: 17.440

3.  Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults.

Authors:  Maria Luisa Briones; José Blanquer; David Ferrando; Maria Luisa Blasco; Concepción Gimeno; Julio Marín
Journal:  Clin Vaccine Immunol       Date:  2006-10

4.  [Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP].

Authors:  Ana Chacón García; Ana Ruigómez; Luis Alberto García Rodríguez
Journal:  Aten Primaria       Date:  2010-09-15       Impact factor: 1.137

5.  Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes.

Authors:  Alberto Capelastegui; Pedro P España; Amaia Bilbao; Julio Gamazo; Federico Medel; Juan Salgado; Iñaki Gorostiaga; Maria Jose Lopez de Goicoechea; Inmaculada Gorordo; Cristobal Esteban; Lander Altube; Jose M Quintana
Journal:  BMC Infect Dis       Date:  2012-06-12       Impact factor: 3.090

6.  Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.

Authors:  Rosario Menéndez; Antoni Torres; Soledad Reyes; Rafael Zalacain; Alberto Capelastegui; Olga Rajas; Luis Borderías; Juan J Martín-Villasclaras; Salvador Bello; Inmaculada Alfageme; Felipe Rodríguez de Castro; Jordi Rello; Luis Molinos; Juan Ruiz-Manzano
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

7.  Lung inflammatory pattern and antibiotic treatment in pneumonia.

Authors:  María-José Lorenzo; Inés Moret; Benjamín Sarria; Enrique Cases; Julio Cortijo; Raúl Méndez; Jose Molina; Alejandra Gimeno; Rosario Menéndez
Journal:  Respir Res       Date:  2015-02-07

Review 8.  [Pneumonia awareness year, 2004: scientific impact through publications in Archivos de Bronconeumología].

Authors:  Olga Rajas Naranjo; Javier Aspa Marco
Journal:  Arch Bronconeumol       Date:  2006-10       Impact factor: 4.872

9.  Serum levels of immunoglobulins and severity of community-acquired pneumonia.

Authors:  Mari C de la Torre; Pere Torán; Mateu Serra-Prat; Elisabet Palomera; Estel Güell; Ester Vendrell; Joan Carles Yébenes; Antoni Torres; Jordi Almirall
Journal:  BMJ Open Respir Res       Date:  2016-11-28

10.  Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia.

Authors:  I Martín-Loeches; J F Bermejo-Martin; J Vallés; R Granada; L Vidaur; J C Vergara-Serrano; M Martín; J C Figueira; J M Sirvent; J Blanquer; D Suarez; A Artigas; A Torres; E Diaz; A Rodriguez
Journal:  Intensive Care Med       Date:  2013-01-24       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.